Effect of chronic cocaine administration on amino acid uptake in rat placental membrane vesicles. 1995

D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
Department of Pediatrics, University of Florida, Gainesville 32610, USA.

This study evaluated the effects of chronic exposure to cocaine during pregnancy on amino acid uptake in placental membrane vesicles. Pregnant rats received 62 mg/kg of cocaine hydrochloride by intraperitoneal (IP) injection as a divided daily dose on gestation days 8-19 inclusive. Fetal body weights were significantly decreased by 19% in the cocaine group, while placental weights were unchanged. Placental apical membrane vesicles were prepared from control and cocaine-treated animals, and marker enzyme enrichments for alkaline phosphatase and [3H]-dihydroalprenolol binding did not differ between cocaine and control groups. Rates of uptake (10 sec) of selected radiolabeled amino acids were measured utilizing a rapid filtration technique. Na(+)-dependent apical membrane [3H]-glutamine transport (50 microM) was reduced by 95% (p < 0.05) in cocaine-treated compared to control placentas. Uptake of 50 microM [3H]-methyl aminoisobutyric acid (MeAIB) into apical membranes was also decreased by 43% (p < 0.05) in cocaine membranes. Na(+)-independent [3H]-arginine transport (10 microM), however, did not differ between control or cocaine-treated groups. In summary, chronic cocaine administration selectively inhibited the transport of glutamine and MeAIB into apical membrane vesicles, but had minimal effect on arginine transport. We postulate that this diminution in uptake may contribute to the fetal growth retardation noted in our model.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D005260 Female Females
D005973 Glutamine A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells. D-Glutamine,L-Glutamine,D Glutamine,L Glutamine
D000621 Aminoisobutyric Acids A group of compounds that are derivatives of the amino acid 2-amino-2-methylpropanoic acid. Acids, Aminoisobutyric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
August 1994, American journal of obstetrics and gynecology,
D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
January 1978, The American journal of physiology,
D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
August 1988, The Journal of clinical endocrinology and metabolism,
D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
September 1993, American journal of obstetrics and gynecology,
D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
February 1987, Nihon Sanka Fujinka Gakkai zasshi,
D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
November 1987, Nihon Sanka Fujinka Gakkai zasshi,
D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
January 1984, Pflugers Archiv : European journal of physiology,
D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
January 1980, Biochimica et biophysica acta,
D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
December 1987, Nihon Sanka Fujinka Gakkai zasshi,
D A Novak, and M J Beveridge, and A S Salhab, and I R Tebbett, and K T Shiverick
January 2006, Methods in molecular medicine,
Copied contents to your clipboard!